These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 20840889)

  • 1. Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: poor adherence and the need to address it.
    Duff AJ; Latchford GJ
    J Cyst Fibros; 2010 Dec; 9(6):455-6. PubMed ID: 20840889
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: A European consensus.
    Heijerman H; Westerman E; Conway S; Touw D; Döring G;
    J Cyst Fibros; 2009 Sep; 8(5):295-315. PubMed ID: 19559658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposable versus reusable jet nebulizers for cystic fibrosis treatment with tobramycin.
    Vecellio L; Abdelrahim ME; Montharu J; Galle J; Diot P; Dubus JC
    J Cyst Fibros; 2011 Mar; 10(2):86-92. PubMed ID: 21075063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled interventions in cystic fibrosis: mucoactive and antibiotic therapies.
    Hurt K; Bilton D
    Respiration; 2014; 88(6):441-8. PubMed ID: 25472021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: three areas for future research Which areas to target? Which particle size to deliver? Which device to use?
    Rottier BL; de Boer AH; Duiverman EJ
    J Cyst Fibros; 2010 Jul; 9(4):296-7. PubMed ID: 20435528
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of inhaled tobramycin in patients with cystic fibrosis].
    Chermenskiĭ AG; Gembitskaia TE
    Ter Arkh; 2010; 82(8):76-8. PubMed ID: 20873251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhalation solutions: which one are allowed to be mixed? Physico-chemical compatibility of drug solutions in nebulizers.
    Kamin W; Schwabe A; Krämer I
    J Cyst Fibros; 2006 Dec; 5(4):205-13. PubMed ID: 16678502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nebuliser systems for drug delivery in cystic fibrosis.
    Daniels T; Mills N; Whitaker P
    Paediatr Respir Rev; 2013 Jun; 14(2):98-9. PubMed ID: 23583049
    [No Abstract]   [Full Text] [Related]  

  • 9. [Inhaled treatments in cystic fibrosis: what's new in 2013?].
    Dubus JC; Bassinet L; Chedevergne F; Delaisi B; Desmazes-Dufeu N; Reychler G; Vecellio L;
    Rev Mal Respir; 2014 Apr; 31(4):336-46. PubMed ID: 24750953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dry powder inhalation versus wet nebulisation delivery of antibiotics in cystic fibrosis patients.
    Westerman EM; Heijerman HG; Frijlink HW
    Expert Opin Drug Deliv; 2007 Mar; 4(2):91-4. PubMed ID: 17335406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Other medications for aerosol delivery.
    Rubin BK
    Paediatr Respir Rev; 2006; 7 Suppl 1():S76-9. PubMed ID: 16798603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing adherence to inhaled therapies in cystic fibrosis.
    Lomas P
    Ther Adv Respir Dis; 2014 Apr; 8(2):39-47. PubMed ID: 24594976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhaled therapies for cystic fibrosis].
    Lahzami S; Nicod LP
    Rev Med Suisse; 2011 Nov; 7(318):2285-8. PubMed ID: 22400363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of different steam disinfection protocols for cystic fibrosis nebulizers.
    Hohenwarter K; Prammer W; Aichinger W; Reychler G
    J Cyst Fibros; 2016 Jan; 15(1):78-84. PubMed ID: 26233897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group.
    Ramsey BW; Pepe MS; Quan JM; Otto KL; Montgomery AB; Williams-Warren J; Vasiljev-K M; Borowitz D; Bowman CM; Marshall BC; Marshall S; Smith AL
    N Engl J Med; 1999 Jan; 340(1):23-30. PubMed ID: 9878641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nebulised bronchodilators, antibiotics and rhDNase for children with cystic fibrosis.
    Spencer DA
    Thorax; 1997 Apr; 52 Suppl 2(Suppl 2):S89-91. PubMed ID: 9155860
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhaled mannitol for the treatment of cystic fibrosis.
    Hurt K; Bilton D
    Expert Rev Respir Med; 2012 Feb; 6(1):19-26. PubMed ID: 22283575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintenance treatment with inhaled ampicillin in patients with cystic fibrosis and lung infection due to methicillin-sensitive Staphylococcus aureus.
    Máiz L; Del Campo R; Castro M; Gutiérrez D; Girón R; Cantón Moreno R
    Arch Bronconeumol; 2012 Oct; 48(10):384. PubMed ID: 22622112
    [No Abstract]   [Full Text] [Related]  

  • 19. Fungal contamination of nebuliser devices used by people with cystic fibrosis.
    Peckham D; Williams K; Wynne S; Denton M; Pollard K; Barton R
    J Cyst Fibros; 2016 Jan; 15(1):74-7. PubMed ID: 26104996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pulmonary deposition of colistin aerosols in cystic fibrosis. Comparison of an ultrasonic nebulizer and a pneumatic nebulizer].
    Gagnadoux F; Diot P; Marchand S; Thompson R; Dieckman K; Lemarié E; Varaigne F; Maurage C; Baulieu JL; Rolland JC
    Rev Mal Respir; 1996; 13(1):55-60. PubMed ID: 8650418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.